L., & Colagiuri, S
Education strengthens the process
Important note for women of childbearing potential: Tirzepatide can reduce the exposure to oral contraceptives during initiation and after each dose escalation
For tirzepatide, stopping at least one month before is widely recommended based on the drugs clearance time, though your provider may advise a longer window
Common adverse effects , particularly during dose escalation, include: Nausea (reported by 2050% of patients, usually mild to moderate) Vomiting, diarrhoea, or constipation Abdominal discomfort or bloating Reduced appetite (therapeutic effect, but may feel unusual initially) Fatigue or headache These effects typically diminish over several weeks as tolerance develops
You know, my patient population is a little bit unique, so I'd probably have to extrapolate their experience more in the broad general sense because [00:06:00] I really feel like these medications are best suited for people who have already gotten their habits in order